Key facts
- Pons’s last known valuation is $10.0M (Jan 2024).
- It has raised $2.8M; the latest was Later Stage VC ($150K) in Jan 2026.
- Notable investors include SOSV, gener8tor, HAX, Unlock Capital (New York), AgeTech Collaborative from AARP — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Pons
- ·The full record, as it builds
Funding rounds
No funding rounds for Pons are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pons
Developer of device-agnostic artificial intelligence software designed to improve ultrasound imaging quality. The company provides deep learning algorithms that enhance scan resolution, tissue contrast, and noise reduction on standard ultrasound devices without additional hardware, enabling healthcare professionals worldwide to achieve expert-level imaging for early disease detection and preventive screening.
- Sector
- Healthcare
- HQ
- Newark, NJ, United States
- Founded
- 2012
- Employees
- 10
- Website
- ponstech.co/
- Ownership
- Privately Held (backing)
Pons doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pons shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pons in its N-PORT filings yet. We sweep new filings monthly.